Effects of chronic inhibition of ACE and AT1 receptors on glomerular injury in Dahl salt-sensitive rats

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 274, Issue 6 43-6, 1998, Pages

  Otsuka, Fumio ^a   Yamauchi, Takayoshi ^a   Kataoka, Hideo ^a   Mimura, Yukari ^a   Ogura, Toshio ^a   Marino, Hirofumi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Glomerulosclerosis; Platelet derived growth factor B chain; Proliferating cell nuclear antigen; Transforming growth factor 1; Type III collagen

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; CYCLINE; DIPEPTIDYL CARBOXYPEPTIDASE;

ANIMAL EXPERIMENT; ARTICLE; ENZYME INHIBITION; GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION RATE; IMMUNOFLUORESCENCE TEST; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RAT; RECEPTOR DENSITY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM EXCRETION; SYSTOLIC BLOOD PRESSURE;

EID: 0031744536     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.1998.274.6.r1797     Document Type: Article

References (33)

1. Abboud, H. E. Platelet-derived growth factor and mesangial cells. Kidney Int. 41: 581-583,1992.
2. Arai, M., A. Wada, Y. Isaka, Y. Akagi, T. Sugiura, M. Miyazaki, T. Moriyama, Y. Kaneda, K. Naruse, M. Naruse, Y. Orita, A. Ando, T. Kamada, N. Ueda, and E. Imai. In vivo transfection of genes for renin and angiotensinogen into the glomerular cells induced phenotypic changes of the mesangial cells and glomerular sclerosis. Biochem. Biophys. Res. Commun. 206:525-532,1995.
3. Bader, M., M. Paul, M. Fernandez-Alfonso, M. Kaling, and D. Ganten. Molecular biology and biochemistry of the reninangiotensin system. In: Textbook of Hypertension, edited by J. D. Swales. London: Blackwell Scientific, 1994, p. 214-232.
4. Border, W. A., S. Okuda, L. R. Languino, M. B. Sporn, and E. Ruoslahti. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor l. Nature 346: 371-374,1990.
5. Chansel, D., S. Czekalski, P. Pham, and R. Ardaillou. Characterization of angiotensin II receptor subtypes in human glomeruli and mesangial cells. Am. J. Physiol. 262 (Renal Fluid Electrolyte Physiol. 31): F432-F441,1992.
6. Collins, T., D. Ginsburg, J. M. Boss, S. H. Orkin, and J. S. Pober. Cultured human endothelial cells express plateletderived growth factor B chain: cDNA cloning and structural analysis. Nature 316: 748-750,1985.
7. Dahl, L. K., M. Heine, and L. Tassinari. Role of genetic factors in susceptibility to experimental hypertension due to chronic excess salt ingestion. Nature 194:480-482,1962.
8. Dahl, L. K., M. Heine, and K. Thompson. Genetic influence of the kidneys on blood pressure. Evidence from chronic renal homografts in rats with opposite predisposition to hypertension. Circ. Res. 34: 94-101,1974.
9. Deynck, R., J. A. Jarrett, E. Y. Chen, D. H. Eaton, J. R. Bell, R. K. Assoian, A. B. Roberts, M. B. Sporn, and D. V. Goeddel. Human transforming growth factor-β complementary DNA sequence, and expression in normal and transformed cells. Nature 316:701-705,1985.
10. Egfjord, M., and K. Olgaard. Aldosterone metabolism in the isolated perfused liver of R and S hypertension-prone Dahl rats. Am. J. Physiol. 262 (Endocrinol. Metab. 25): E488-E496,1992.
11. Gomez, R. A. Angiotensin receptors: relevance in development and disease states. Exp. Nephrol. 2: 259-268,1994.
12. Hall, J. E., A, C. Guyton, H. C. Salgado, R. E. McCaa, and J. W. Balfe. Renal hemodynamics in acute and chronic angiotensin II hypertension. Am. J. Physiol. 235 (Renal Fluid Electrolyte Physiol. 4): F174-F179,1978.
13. Hirawa, N., Y. Uehara, Y. Kawabata, N. Ohshima, H. Ono, T. Nagata, T. Gomi, T. Ikeda, A. Goto, S. Yagi, and M. Omata. Mechanistic analysis of renal protection by angiotensin converting enzyme inhibitor in Dahl salt-sensitive rats. J. Hypertens. 12: 909-918,1994.
14. Hu, L., and D. Manning. Role of nitric oxide in regulation of long-term pressure-natriuresis relationship in Dalil rats. Am. J. Physiol. 268 (Heart Circ. Physiol. 37): H2375-H2383,1995.
15. Ichiki, T., P. A. Labosky, C. Shiota, S. Okuyama, Y. Imagawa, A. Fogo, F. Niimura, I. Ichikawa, B. L. M. Hogan, and T. Inagami. Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type 2 receptor. Nature 377:748-750, 1995.
16. Inagami, T., D. F. Guo, and Y. Kitami. Molecular biology of angiotensin II receptors: an overview. J. Hypertens. Suppl. 12: S83-S94,1994.
17. Isaka, Y., Y. Fujiwara, N. Ueda, Y. Kaneda, T. Kamada, and E. Imai. Glomerulosclerosis induced by in vivo transfection of transforming growth factor-β or platelet-derived growth factor gene into the rat kidney. J. Clin. Invest. 92:2597-2601,1993.
18. Johnson, R. J., C. E. Alpers, A. Yoshimura, D. Lombardi, P. Pritzl, J. Floege, and S. M. Schwartz. Renal injury from angiotensin II-mediated hypertension. Hypertension 19: 464474,1992.
19. Kaneto, H., J. Morrissey, and S. Klahr. Increased expression of TGF-β1 mRNAin the obstructed kidney of rats with unilateral ureteral ligation. Kidney Int. 44:313-321,1993.
20. Ketteler, M., N. A. Noble, and W. A. Border. Transforming growth factor beta and angiotensin II: the missing link from glomerular hyperfiltration to glomerulosclerosis? Anna. Rev. Physiol. 57:279-295,1995.
21. Kim, S., K. Ohta, A. Hamaguchi, T. Omura, T. Yukimura, K. Miura, Y. Inada, T. Wada, Y. Ishihara, F. Chatani, and H. Iwao. Role of angiotensin II in renal injury of deoxycorticosterone acetate-salt hypertensive rats. Hypertension 24: 195-204, 1994.
22. Kirn, S., K. Ohta, A. Hamaguchi, T. Omura, T. Yukimura, K. Miura, Y. Inada, T. Wada, Y. Ishimura, F. Chatani, and H. Iwao. Contribution of renal angiotensin II type 1 receptor to gene expression in hypertension-induced renal injury. Kidney Int. 46:1346-1358,1994.
23. Nakajima, M., H. G. Hutchinson, M. Fujinaga, W. Hayashida, R. Morishita, L. Zhang, M. Horiuchi, R. E. Pratt, and V. J. Dzau. The angiotensin II type 2 (AT2) receptor antagonizes the growth effect of the ATI receptor: gain-offunction study using gene transfer. Proc. Natl. Acad. Sei. USA 92:10663-10667,1995.
24. O'Donnell, M. P., B. L. Kasiske, S. A. Katz, P. G. Schmits, and W. F. Kaane. Lovastatin but not enalapril reduces glomerular injury in Dahl salt-sensitive rats. Hypertension 20: 651-658, 1992.
25. Oishi, T., T. Ogura, T. Yamauchi, K. Ilarada, and Z. Ota. Effect of renin-angiotensin inhibition on glomerular injuries in DOCA-salt hypertensive rats. Regul. Pept. 62:89-95,1996.
26. Raij, L., S. Azar, and W. Keane. Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats. Kidney Int. 26:137-143,1984.
27. Reiss, K., L. G. Meggs, P. Li, G. Olivetti, J. Capasso, and P. Anversa. Upregulation of IGF1, IGFl-receptor, and late growthrelated genes in ventricular myocytes acutely after infarction in rats. J. Cell. Physiol. 158:160-168,1994.
28. Sechi, L. A., E. F. Grady, C. A. Griffin, J. E. Kalinyak, and M. Schambelan. Distribution of angiotensin II receptor subtypes in rat and human kidney. Am. J. Physiol. 262 (Renal Fluid Electrolyte Physiol. 31): F236-F240,1992.
29. Von Lutterotti, N., M. J. Camargo, W. G. Campbell, Jr., F. B. Mueller, P. B. Timmermans, J. E. Sealey, and J. H. Laragh. Angiotensin II receptor antagonist delays renal damage and stroke in salt-loaded Dahl salt-sensitive hypertensive rats. J. Hypertens. 10:949-957,1992.
30. Wada, T., Y. Inada, T. Sanada, M. Ojima, Y. Shibouta, M. Noda, and K. Nishikawa. Effect of an angiotensin II receptor antagonist, CV-11974, and its prodrug, TCV-116, on production of aldosterone. Eur. J. Pharmacol. 253:27-34,1994.
31. Wolf, G., and E. G. Neilson. Angiotensin II as a renal growth factor. J. Am. Soc. Nephrol. 3:1531-1540,1993.
32. Yamada, T., M. Horinouchi, and V. J. Dzau. Angiotensin II type 2 receptor mediates programmed cell death. Proc. Natl. Acad. Sei. USA 93:156-160,1996.
33. Yamauchi, T., T. Ogura, T. Oishi, T. Omiya, and Z. Ota. The angiotensin I-converting enzyme inhibitor, cilazapril, inhibits the platelet derived growth factor B chain expression in glomeruli of spontaneously hypertensive rats. Renal Physiol. Biochem. 18:237-245,1995.